Search for: "CIPLA" Results 21 - 40 of 202
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2015, 9:15 am by Thomas Valenti
Roche filed an infringement suit against Cipla in Delhi High Court in January 2008. [read post]
24 Dec 2014, 9:50 am by Ron Coleman
 Judge Michel was the CIPLA’s keynote speaker. [read post]
15 Jun 2014, 11:30 pm by Kingsley Egbuonu
As nosy as he is, this Leo went further to validate the point made by Cipla in that article by MIP. [read post]
23 Apr 2014, 9:59 pm by Patent Docs
Cipla Ltd. et al. 1:14-cv-00427; filed April 7, 2014 in the District Court of Delaware • Plaintiffs: Helsinn Healthcare S.A.; Roche Palo Alto LLC • Defendants: Cipla Ltd.; Cipla USA Inc. [read post]
14 Mar 2014, 3:22 am
Doors open at 6 pm and the screening is from 7.30 pm – 8.15 pm, followed by a question and answer session with Chairman of Cipla, Dr Yusuf Hamied. [read post]
12 Mar 2014, 12:58 pm by Ron Coleman
 Judge Michel was the CIPLA’s keynote speaker. [read post]
5 Mar 2014, 12:01 pm by Ron Coleman
Anyway, I am grateful to IP diva-in-the-making Katherine Eppley of Pearne & Gordon for suggesting that CIPLA invite me to rock in Cleveland next Monday, whatever on earth that means (I mean “the rocking” — the “invitation” I made sure to get in writing). [read post]
13 Feb 2014, 9:04 am
Cipla filed an Abbreviated New Drug Application ("ANDA") with the U.S. [read post]
16 Aug 2013, 7:48 pm by Prashant Reddy
Some of the biggest violators of the Drug Price Control Order (DPCO) have been Indian generics like Cipla. [read post]
3 Aug 2013, 6:35 am by Anubha Sinha
In another instance, when Big pharma threatened legal action against the South African government in the latter's efforts to bring down prices for HIV-AIDS treatment, Indian pharma major Cipla stepped in and offered to supply drugs at just $350 per patient per year. [read post]
8 Jun 2013, 10:35 am by Madhulika Vishwanathan
The appellant (Sugen) argued that respondent (Cipla’s) reply statement had been filed beyond time and request for extension had not been made within prescribed period and therefore should not have been considered by Controller. [read post]
2 Apr 2013, 8:30 am by Madhulika Vishwanathan
It will be interesting to see whether the courts follow the Roche vs Cipla reasoning or have an entirely different take on this altogether.We will keep you posted! [read post]
1 Apr 2013, 3:55 am by Prashant Reddy
The patent application had initially been rejected by the Controller of Patents in 2006, after hearing 5 pre-grant oppositions filed by various generic pharmaceutical companies including Ranbaxy, Cipla, Hetero and one patients group – the Cancer Patient Aid Association (CPAA). [read post]
8 Mar 2013, 2:47 am by Sai Vinod
 The Board then deliberated on the suppression of CIPLA’s presence and the filing of counterclaims by the respondent and the false s [read post]
7 Mar 2013, 3:21 pm by Swaraj Paul Barooah
The confirmed speakers for Pharma IPR 2013 taking place from 10-12 April at Holiday Inn Mumbai International Airport, Mumbai, India are as follows:- Jeffrey Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi (USA)- Sri K Sankaran, Partner, Winthrop & Weinstine (USA)- Rowan Forster, Director, Edward Nathan Sonnenbergs (South Africa)- Mariko Mimura, Director, Head of Legal/IP Japan, Novartis Holding (Japan)- Mia Qu, Partner, King & Wood Mallesons (China)- Alka Mehta, Head IPR,… [read post]